Lewis-Hall Freda C
SEC-identified person · CIK 1437909 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Pyxis Oncology, Inc. PYXS | Director | filed 2021–2026 |
| Murphy Canyon Acquisition Corp. MURF | Director | filed 2023–2025 |
| Springworks Therapeutics, Inc. [SWTX | Director | filed 2019–2025 |
| Exact Sciences Corp EXAS | Director | filed 2020–2023 |
| 1Life Healthcare Inc ONEM | Director | filed 2020–2023 |
| Pfizer INC pfe | Senior Vice President | filed 2009–2019 |
| Tenet Healthcare Corp THC | Director | filed 2014–2016 |
| Vertex Pharmaceuticals INC / MA VRTX | EVP, Medicines Development | filed 2008–2009 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.